BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 630888)

  • 1. Early abortion by vaginal prostaglandin suppositories. Blood loss in relation to elimination of serum chorionic gonadotrophin, progesterone and estradiol-17 beta.
    Hamberger L; Nilsson L; Björn-Rasmussen E; Atterfelt P; Wiqvist N
    Contraception; 1978 Feb; 17(2):183-93. PubMed ID: 630888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Wan LS; Stiber AJ; Turkel J
    Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
    Marrs RP; Brenner PF; Roy S; Mishell DR
    Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
    Mandelin M
    Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
    Bygdeman M; Martin JN; Eneroth P; Leader A; Lundström V
    Am J Obstet Gynecol; 1976 Mar; 124(5):495-8. PubMed ID: 1258906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual regulation with prostaglandin (Pg ONO 802) in Indonesia.
    Agoestina T; Sastrawinata S; Prayitno W; Gonta P
    Int J Gynaecol Obstet; 1984 Oct; 22(5):403-9. PubMed ID: 6151928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.
    Birgerson L; Odlind V
    Fertil Steril; 1987 Oct; 48(4):565-70. PubMed ID: 3653415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a single vaginal suppository containing 15-methyl PGF2 alpha methyl ester at expected time of menstruation.
    Kinoshita K; Eneroth P; Bygdeman M
    Prostaglandins; 1979 Mar; 17(3):469-81. PubMed ID: 472340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy-abortion model using sulprostone.
    Fleischer A; Schulman H; Blattner P; Jagani N; Fayemi A
    Prostaglandins; 1982 May; 23(5):643-55. PubMed ID: 7122906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.